Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis

<p><span data-sheets-value= "{"1":2,"2":"Dr. Gordon Smith talks with Dr. Vera Bril about exploring the potential use of immunoglobulin as a corticosteroid-sparing agent in patients with Myasthenia Gravis. \n\nRead the related article in Neurology."}" data-sheets-userformat= "{"2":13187,"3":{"1":0},"4":{"1":2,"2":14277081},"10":1,"11":4,"12":0,"15":"Calibri","16":12}"> Dr. Vera Bril discusses her paper, "Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis". <br /> <br /></span>Show references: <span data-sheets-value= "{"1":2,"2":"https://doi.org/10.1212/WNL.0000000000201501"}" data-sheets-userformat= "{"2":31699,"3":{"1":0},"4":{"1":2,"2":14277081},"7":{"1":[{"1":2,"2":0,"5":{"1":2,"2":0}},{"1":0,"2":0,"3":3},{"1":1,"2":0,"4":3}]},"9":1,"10":1,"11":4,"12":0,"14":{"1":2,"2":0},"15":"Calibri","16":12,"17":1}" data-sheets-hyperlink= "https://doi.org/10.1212/WNL.0000000000201501"><a class= "in-cell-link" href="https://doi.org/10.1212/WNL.0000000000201501" target="_blank" rel= "noopener">https://doi.org/10.1212/WNL.0000000000201501</a></span></p>